Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Commonly Reported Side Effects Based on community reports, side effects appear relatively uncommon and typically mild: Most Frequently Reported: Injection site reactions (redness, minor pain, itching) Mild nausea (particularly with oral administration) Temporary dizziness Headache Fatigue Less Commonly Reported: Skin flushing Changes in appetite Temporary mood changes Vivid dreams Theoretical Concerns Growth Factor Effects: BPC-157's upregulation of growth factors raises theoretical concerns for: Cancer promotion in those with existing malignancies Acceleration of undiagnosed tumors Effects on benign growths (polyps, fibroids) No evidence directly supports these concerns, but caution is warranted given the mechanisms involved
Backed by our 30 Day No Questions Asked, Money-Back Guarantee
Under section 503A, a licensed pharmacist in a state-licensed pharmacy or federal facility, or a licensed physician who compounds, may use a bulk drug substance through one of three statutory routes
If tirzepatide is producing the desired outcomes, there is no compelling reason to switch to a less proven compound with more side effects
